Skip to main content

Immunome Inc. (IMNM)

Sector
Healthcare
Industry
Biotechnology
Last price
$17.18
As of

Kresmion compiles this page from IMNM's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.

Immunome Inc. (IMNM): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-11-09.

As of . Source: SEC EDGAR filings for IMNM. Method and limitations.

COMPANY DOSSIER

See the full IMNM dossier

Price with insider and filing markers, who is positioning, fundamentals and peers for IMNM on one page. Preview it with sample data, then open it live with a free account.

Preview the IMNM dossier

Active events for IMNM

FREE, NO ACCOUNT

Every event on IMNM, as it fires

You are seeing 5 of 10 events recorded on IMNM since 2026-06-20.

The five above landed across 4 days. The other 5 were recorded on 2 other days. 6 of the 10 are institutional flow rows, which arrive in batches on filing days.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

No non-option holdings from tracked managers in this reporting quarter. Other reporting quarters are linked above.

Recent SEC filings, IMNM

More data on IMNM

IMNM against its peers

IMNM's operating margin of -3228.8% ranks in the 19th percentile of 17 Biotechnology sub-industry peers, fiscal periods ending between 2025-12-31 and 2026-03-31.

MetricIMNMPeer medianPercentilen
Revenue FY6.9M USD90.3M USD1516
Gross marginn/a87.7%n/a8
Operating margin-3228.8%-148.6%1917
Net margin-3060.0%-78.3%1917
Return on equity-33.5%-35.8%5422
1 year-0.5%9.3%3722

Peers (23): CLDX, VERA, ZYME, RXRX, BHVN, LKFT, NAMS, PHVS, AUPH, REPL, PVLA, RCUS, MBX, SEPN, VCYT, BCRX, MAZE, XNCR, ATAI.D, AGIO, ZBIO, BEAM, ADMA. Left out: ZLDPF (no annual filing), TRAX (no annual filing). Fiscal periods ending between 2025-12-31 and 2026-03-31. Every figure is one full fiscal year read from one annual filing (IMNM: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.

Cite this data

Kresmion counts the managers it follows that reported a non-option position in IMNM on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on IMNM in the last 180 days.

Upstream: SEC EDGAR filings for IMNM

Kresmion, "Immunome Inc. (IMNM) institutional holdings and SEC filings", data as of 2026-11-13, https://kresmion.com/research/IMNM. Upstream data: SEC EDGAR filings for IMNM.

Link to this data (HTML):

<a href="https://kresmion.com/research/IMNM">Immunome Inc. (IMNM) institutional holdings and SEC filings (Kresmion)</a>

Writing about this? Press contact and ready-to-quote figures

Follow IMNM on a live board

Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to IMNM for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.

Preview the IMNM dossier
Share

The IMNM intelligence card: the smart money composite, cross family confluence and the top current signal, with a link back to this page.